SPDR S&P Biotech ETF (XBI) Short Interest Update

SPDR S&P Biotech ETF (NYSEARCA:XBI) was the target of a significant decrease in short interest in February. As of February 28th, there was short interest totalling 35,955,877 shares, a decrease of 7.6% from the February 15th total of 38,923,643 shares. Based on an average daily trading volume, of 4,464,640 shares, the days-to-cover ratio is currently 8.1 days.

Shares of XBI opened at $91.24 on Wednesday. SPDR S&P Biotech ETF has a 52 week low of $64.38 and a 52 week high of $101.55.

Get SPDR S&P Biotech ETF alerts:

A number of institutional investors and hedge funds have recently modified their holdings of the business. Northern Trust Corp boosted its stake in shares of SPDR S&P Biotech ETF by 56.9% in the 2nd quarter. Northern Trust Corp now owns 4,935 shares of the exchange traded fund’s stock valued at $470,000 after purchasing an additional 1,789 shares during the last quarter. JPMorgan Chase & Co. lifted its stake in SPDR S&P Biotech ETF by 98.7% in the third quarter. JPMorgan Chase & Co. now owns 3,265,715 shares of the exchange traded fund’s stock valued at $313,084,000 after buying an additional 1,622,372 shares in the last quarter. Candriam Luxembourg S.C.A. lifted its stake in SPDR S&P Biotech ETF by 26.5% in the third quarter. Candriam Luxembourg S.C.A. now owns 3,705 shares of the exchange traded fund’s stock valued at $355,000 after buying an additional 775 shares in the last quarter. MML Investors Services LLC lifted its stake in SPDR S&P Biotech ETF by 15.1% in the third quarter. MML Investors Services LLC now owns 46,705 shares of the exchange traded fund’s stock valued at $4,478,000 after buying an additional 6,135 shares in the last quarter. Finally, Claraphi Advisory Network LLC lifted its stake in SPDR S&P Biotech ETF by 46.4% in the third quarter. Claraphi Advisory Network LLC now owns 3,456 shares of the exchange traded fund’s stock valued at $331,000 after buying an additional 1,096 shares in the last quarter.

ILLEGAL ACTIVITY NOTICE: “SPDR S&P Biotech ETF (XBI) Short Interest Update” was published by Ticker Report and is the property of of Ticker Report. If you are reading this piece of content on another site, it was illegally stolen and republished in violation of U.S. & international copyright laws. The legal version of this piece of content can be viewed at www.tickerreport.com/banking-finance/4234081/spdr-sp-biotech-etf-xbi-short-interest-update.html.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Recommended Story: What is the Gross Domestic Product (GDP)?

Leave a Reply

Your email address will not be published. Required fields are marked *